Clinical assessment of novel therapies is paramount in ensuring the future of beneficial heal
read MoreCyclotek’s product portfolio has been expanded by the addition of dopamine transporter radi
read MorePatients will no longer need to pay for these scans themselves and will have equitable access
read MoreApplied Molecular Therapies (AMT) has announced a successful TGA licence upgrade for the GMP
read MoreCyclotek’s Media Associate Nicoletta Snellen recently sat down with Eden Carnegie, Quality
read MoreCyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australiaâ
read More[contact-form-7 id=”714″ title=”Update Form”]